Special Issue "The Impact of Vaccines against Infectious Diseases on Non-communicable Diseases"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (10 May 2022) | Viewed by 508
Interests: atherosclerosis; endothelial injury and repair; vascular regeneration; inflammation; immune tolerance; cancer; HIV infection; COVID-19
Interests: atherosclerosis;endothelial injury and repair; vascular regeneration; inflammation; lipid-lowering nutraceuticals; HIV infection; COVID-19
The availability of an efficacious prophylactic vaccine is a crucial means to preventing a number of infectious diseases. However, there is still an incomplete understanding of the possible interplay, either protective or detrimental, between immune response pathways elicited by vaccines and the physiopathology of non-communicable diseases in receiving subjects. This may be of crucial interest now that a vaccination plan to prevent infection with SARS-CoV-2 is about to be extended to the population worldwide.
This Special Issue aims to achieve a more extensive understanding of current scientific knowledge on the possible protective/detrimental role of vaccines against infectious diseases on the prevention and management of non-communicable diseases.
Dr. Vanessa Bianconi
Dr. Massimo Raffaele Mannarino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- non-communicable disease